| |
| |
|
| Insider
Information: |
Wagner Heidi L |
| Relationship: |
SVP, Global Government... |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
49,140 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,968,050 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,140 |
|
|
| Total
Value |
$8,968,050 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
SVP, Global Government... |
2018-02-28 |
49,140 |
2015-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
24 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2018-02-28 |
4 |
S |
$118.61 |
$53,849 |
D/D |
(454) |
49,140 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2018-02-27 |
4 |
S |
$120.72 |
$29,456 |
D/D |
(244) |
49,594 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2018-02-08 |
4 |
S |
$116.31 |
$206,334 |
D/D |
(1,774) |
49,838 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
18,977 |
51,612 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2018-02-05 |
4 |
S |
$117.26 |
$76,805 |
D/D |
(655) |
32,635 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-10-02 |
4 |
S |
$140.00 |
$16,800 |
D/D |
(120) |
33,290 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-03-01 |
4 |
S |
$132.50 |
$20,670 |
D/D |
(156) |
29,010 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-02-28 |
4 |
S |
$131.70 |
$63,216 |
D/D |
(480) |
29,166 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
4,400 |
33,410 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-02-27 |
4 |
S |
$131.20 |
$46,970 |
D/D |
(358) |
29,646 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-02-07 |
4 |
S |
$128.09 |
$28,436 |
D/D |
(222) |
30,004 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2017-02-06 |
4 |
S |
$125.69 |
$214,935 |
D/D |
(1,710) |
30,226 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-11-14 |
4 |
S |
$115.10 |
$6,791 |
D/D |
(59) |
31,936 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-10-03 |
4 |
S |
$122.41 |
$14,689 |
D/D |
(120) |
31,995 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-08-08 |
4 |
S |
$137.14 |
$30,445 |
D/D |
(222) |
32,115 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-05-13 |
4 |
S |
$138.65 |
$7,348 |
D/D |
(53) |
32,337 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-29 |
4 |
S |
$138.91 |
$75,984 |
D/D |
(547) |
32,390 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
32,937 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-08 |
4 |
S |
$138.02 |
$130,066 |
D/D |
(942) |
29,937 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-05 |
4 |
S |
$141.55 |
$142,708 |
D/D |
(997) |
30,879 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-04 |
4 |
A |
$0.00 |
$0 |
D/D |
6,129 |
31,876 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2016-02-04 |
4 |
S |
$143.81 |
$24,309 |
D/D |
(169) |
25,747 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2015-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,916 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
SVP, Global Government Affairs |
• – – |
2015-10-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,000 |
13,458 |
0 |
- |
|
24 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
